2-tert-butylhydroquinone has been researched along with Glaucoma, Suspect in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X; Yuan, ZL | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Glaucoma, Suspect
| Article | Year |
|---|---|
Activation of Nrf2/HO-1 pathway protects retinal ganglion cells from a rat chronic ocular hypertension model of glaucoma.
Topics: Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Glaucoma; Heme Oxygenase-1; Hydroquinones; NF-E2-Related Factor 2; Ocular Hypertension; Rats; Retinal Ganglion Cells | 2019 |